-
Cardinal Health’s annual research report examines milestone year in biosimilars
The study reveals the impact of a dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability. -
Cardinal Health releases fiscal 2023 ESG report
Cardinal Health has reduced its Scope 1 and Scope 2 greenhouse gas emissions by 13%, making progress toward its fiscal 2030 50% reduction goal.